Genomic and proteomic approaches to vaccine candidate identification for Anaplasma marginale
- PMID: 16451111
- DOI: 10.1586/14760584.5.1.95
Genomic and proteomic approaches to vaccine candidate identification for Anaplasma marginale
Abstract
Outer membrane protein preparations have been demonstrated to elicit protective immunity for Anaplasma marginale. Attempts to recreate this protective immunity using known surface proteins have been unsuccessful; therefore, novel outer membrane proteins have been searched for using a proteomic/genomic approach. Annotation of the whole genome sequence identified 62 outer membrane protein candidates based on sequence similarity to known surface proteins. In a proteomics approach for the identification of immunostimulatory outer membrane proteins, outer membrane preparations that were separated on 2D gels were used to immunize calves . Antisera from the calves were used to detect immunoreactive proteins, which were then selected and subjected to mass spectrometric analyses. These data were mapped back to the annotated A. marginale genome and have identified several new outer membrane proteins that are vaccine candidates.
Similar articles
-
Anaplasma marginale: Diversity, Virulence, and Vaccine Landscape through a Genomics Approach.Biomed Res Int. 2016;2016:9032085. doi: 10.1155/2016/9032085. Epub 2016 Aug 17. Biomed Res Int. 2016. PMID: 27610385 Free PMC article. Review.
-
Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping.Infect Immun. 2005 Dec;73(12):8109-18. doi: 10.1128/IAI.73.12.8109-8118.2005. Infect Immun. 2005. PMID: 16299305 Free PMC article.
-
Molecular conservation of MSP4 and MSP5 in Anaplasma marginale and A. centrale vaccine strain.Vet Microbiol. 2004 May 20;100(1-2):55-64. doi: 10.1016/j.vetmic.2004.01.018. Vet Microbiol. 2004. PMID: 15135513
-
Identification of Anaplasma marginale outer membrane protein antigens conserved between A. marginale sensu stricto strains and the live A. marginale subsp. centrale vaccine.Infect Immun. 2011 Mar;79(3):1311-8. doi: 10.1128/IAI.01174-10. Epub 2010 Dec 28. Infect Immun. 2011. PMID: 21189322 Free PMC article.
-
Genetic diversity of anaplasma species major surface proteins and implications for anaplasmosis serodiagnosis and vaccine development.Anim Health Res Rev. 2005 Jun;6(1):75-89. doi: 10.1079/ahr2005104. Anim Health Res Rev. 2005. PMID: 16164010 Review.
Cited by
-
Identification of Anaplasma marginale adhesins for entry into Dermacentor andersoni tick cells using phage display.Infect Immun. 2024 Jun 11;92(6):e0054023. doi: 10.1128/iai.00540-23. Epub 2024 May 10. Infect Immun. 2024. PMID: 38727242 Free PMC article.
-
Sequence and immunologic conservation of Anaplasma marginale OmpA within strains from Ghana as compared to the predominant OmpA variant.PLoS One. 2019 Jul 10;14(7):e0217661. doi: 10.1371/journal.pone.0217661. eCollection 2019. PLoS One. 2019. PMID: 31291256 Free PMC article.
-
Anaplasma marginale: Diversity, Virulence, and Vaccine Landscape through a Genomics Approach.Biomed Res Int. 2016;2016:9032085. doi: 10.1155/2016/9032085. Epub 2016 Aug 17. Biomed Res Int. 2016. PMID: 27610385 Free PMC article. Review.
-
The genus Anaplasma: drawing back the curtain on tick-pathogen interactions.Pathog Dis. 2021 Apr 22;79(5):ftab022. doi: 10.1093/femspd/ftab022. Pathog Dis. 2021. PMID: 33792663 Free PMC article. Review.
-
Anaplasma marginale type IV secretion system proteins VirB2, VirB7, VirB11, and VirD4 are immunogenic components of a protective bacterial membrane vaccine.Infect Immun. 2010 Mar;78(3):1314-25. doi: 10.1128/IAI.01207-09. Epub 2010 Jan 11. Infect Immun. 2010. PMID: 20065028 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources